Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A 16-Week, Multicenter, Randomized, Open-label Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
This study ended early.
Multiple locations, including BrusselsAn Open-label, Single-arm, Multicenter, Phase IV Study to Evaluate the Response to Treatment and Safety of Flexible Dose Treatment With Extended-release Paliperidone in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AdanaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaA Phase I Study to Determine the Pharmacokinetics of Buspirone from a Metered Dose Transdermal System (MDTS) in anxiety
This study has finished and is no longer accepting participants.
Location not clearly listedA Phase I, Prospective, Randomized, Double-blind, Placebo-controlled, Sequential-cohort, Escalating, Single-dose Study Designed to Determine the Maximum Tolerated Oral Dose of NW-3509A in Healthy, Male Volunteers.
This study has finished and is no longer accepting participants.
In Long BeachA Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
This study has finished and is no longer accepting participants.
Multiple locations, including DenverThis study evaluates the safety and effectiveness of NS-136 for people with schizophrenia.
This study is by invitation only.
In ShanghaiThis study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SpainThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.